G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -40.0% | 300 | -72.7% | 0.00% | – |
| Q2 2022 | $5,000 | -37.5% | 1,100 | -21.4% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 1,400 | +27.3% | 0.00% | – |
| Q4 2021 | $11,000 | -80.4% | 1,100 | -81.4% | 0.00% | -100.0% |
| Q3 2021 | $56,000 | 0.0% | 5,900 | -1.7% | 0.00% | +50.0% |
| Q2 2021 | $56,000 | -5.1% | 6,000 | +30.4% | 0.00% | 0.0% |
| Q1 2021 | $59,000 | +227.8% | 4,600 | +4.5% | 0.00% | +100.0% |
| Q4 2020 | $18,000 | 0.0% | 4,400 | -24.1% | 0.00% | 0.0% |
| Q3 2020 | $18,000 | -10.0% | 5,800 | +152.2% | 0.00% | 0.0% |
| Q2 2020 | $20,000 | +100.0% | 2,300 | -25.8% | 0.00% | – |
| Q1 2020 | $10,000 | -85.9% | 3,100 | +3.3% | 0.00% | -100.0% |
| Q4 2019 | $71,000 | +16.4% | 3,000 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $61,000 | +6000.0% | 3,000 | +2900.0% | 0.01% | – |
| Q1 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |